Literature DB >> 10997393

Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy.

G Boivin1, A Gaudreau, J P Routy.   

Abstract

OBJECTIVES: To evaluate the human herpesvirus 8 (HHV-8) DNA load in peripheral blood mononuclear cells (PBMC) and Kaposi's sarcoma (KS) skin lesions of subjects with AIDS and to correlate these measures with the tumour load.
DESIGN: Assessment of the HHV-8 DNA load was performed every 3 months in PBMC and every 6 months in KS skin lesions from seven subjects with AIDS who were receiving highly active antiretroviral therapy (HAART).
METHODS: The HHV-8 DNA load was determined by a quantitative-competitive PCR using 0.2 microg of DNA from PBMC or KS skin biopsies. Staging of KS was performed by evaluating the number and type of cutaneous KS lesions.
RESULTS: The three subjects with the most extensive and active (nodular) KS had the highest amounts of HHV-8 DNA in KS skin lesions and the lowest CD4 T cell counts (< 200 x 10(6)/l). In contrast, the four other subjects with regressing KS while on HAART had a low viral load in their KS lesions. All but one subject who also had multicentric Castleman's disease had low amounts of HHV-8 DNA in PBMC.
CONCLUSION: There is a strong relationship between the tumour burden and the HHV-8 viral load in KS skin lesions of subjects with AIDS, reinforcing the causal link between this herpesvirus and AIDS-related KS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997393     DOI: 10.1097/00002030-200009080-00004

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  13 in total

1.  Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV.

Authors:  Zhiqiang Qin; Michael DeFee; Jennifer S Isaacs; Chris Parsons
Journal:  Virology       Date:  2010-05-06       Impact factor: 3.616

2.  Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis.

Authors:  Adam Grundhoff; Don Ganem
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

3.  Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in Central African Republic.

Authors:  Renan Duprez; Eric Kassa-Kelembho; Sabine Plancoulaine; Josette Brière; Mireille Fossi; Léon Kobangue; Pierre Minsart; Michel Huerre; Antoine Gessain
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Viral load of human herpesvirus 8 in peripheral blood of human immunodeficiency virus-infected patients with Kaposi's sarcoma.

Authors:  R Tedeschi; M Enbom; E Bidoli; A Linde; P De Paoli; J Dillner
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

5.  An endothelial cell line infected by Kaposi's sarcoma-associated herpes virus (KSHV) allows the investigation of Kaposi's sarcoma and the validation of novel viral inhibitors in vitro and in vivo.

Authors:  Tatyana Dubich; Anna Lieske; Susann Santag; Guillaume Beauclair; Jessica Rückert; Jennifer Herrmann; Jan Gorges; Guntram Büsche; Uli Kazmaier; Hansjörg Hauser; Marc Stadler; Thomas F Schulz; Dagmar Wirth
Journal:  J Mol Med (Berl)       Date:  2019-01-04       Impact factor: 4.599

6.  Calibrated real-time PCR assay for quantitation of human herpesvirus 8 DNA in biological fluids.

Authors:  Francesco Broccolo; Giuseppe Locatelli; Loredana Sarmati; Sara Piergiovanni; Fabrizio Veglia; Massimo Andreoni; Stefano Buttò; Barbara Ensoli; Paolo Lusso; Mauro S Malnati
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

7.  The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection.

Authors:  Jie Lu; Subhash C Verma; Qiliang Cai; Erle S Robertson
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

8.  Multiple remissions of extracavitary primary effusion lymphoma treated with a single cycle of liposomal doxorubicin in a patient infected with HIV.

Authors:  J Chen; V Mehraj; J Szabo; B Routy; R P Michel; J P Routy
Journal:  Curr Oncol       Date:  2018-12-01       Impact factor: 3.677

9.  Evidence for both lytic replication and tightly regulated human herpesvirus 8 latency in circulating mononuclear cells, with virus loads frequently below common thresholds of detection.

Authors:  Elisa Martró; Michael J Cannon; Sheila C Dollard; Thomas J Spira; A Scott Laney; Chin-Yih Ou; Philip E Pellett
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

Review 10.  Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases.

Authors:  Dharam V Ablashi; Louise G Chatlynne; James E Whitman; Ethel Cesarman
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.